{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:02:17Z","timestamp":1761663737500,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81200628"],"award-info":[{"award-number":["81200628"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["12ZR1417800"],"award-info":[{"award-number":["12ZR1417800"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Fund","doi-asserted-by":"crossref","award":["08411953000"],"award-info":[{"award-number":["08411953000"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12958-018-0331-4","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:00:27Z","timestamp":1522800027000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Circulating osteopontin and its association with liver fat content in non-obese women with polycystic ovary syndrome: a case control study"],"prefix":"10.1186","volume":"16","author":[{"given":"Yuying","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzuchun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"issue":"11","key":"331_CR1","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","volume":"84","author":"E Diamanti-Kandarakis","year":"1999","unstructured":"Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, et al. A survey of the polycystic ovary syndrome in the Greek island of lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab. 1999;84(11):4006.","journal-title":"J Clin Endocrinol Metab"},{"key":"331_CR2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1055\/s-2007-967093","volume":"115","author":"S Hahn","year":"2007","unstructured":"Hahn S, Tan S, Sack S, Kimmig R, Quadbeck B, Mann K, et al. Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2007;115:130\u20135.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"331_CR3","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","volume":"98","author":"RS Legro","year":"2013","unstructured":"Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98:4565\u201392.","journal-title":"J Clin Endocrinol Metab"},{"key":"331_CR4","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/S1472-6483(10)61644-6","volume":"8","author":"R Azziz","year":"2004","unstructured":"Azziz R. PCOS: a diagnostic challenge. Reprod BioMed Online. 2004;8:644\u20138.","journal-title":"Reprod BioMed Online"},{"key":"331_CR5","first-page":"201","volume":"57","author":"D Uchil","year":"2009","unstructured":"Uchil D, Pipalia D, Chawla M, Patel R, Maniar S. Narayani, et al. non-alcoholic fatty liver disease (NAFLD)--the hepatic component of metabolic syndrome. J Assoc Physicians India. 2009;57:201\u20134.","journal-title":"J Assoc Physicians India"},{"key":"331_CR6","first-page":"725","volume":"11","author":"Z Qu","year":"2013","unstructured":"Qu Z, Zhu Y, Jiang J, Shi Y, Chen Z. The clinical characteristics and etiological study of nonalcoholic fatty liver disease in Chinese women with PCOS. Iran J Reprod Med. 2013;11:725\u201332.","journal-title":"Iran J Reprod Med"},{"key":"331_CR7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jhep.2007.04.012","volume":"47","author":"C Cerda","year":"2007","unstructured":"Cerda C, Perez-Ayuso RM, Riquelme A, Soza A, Villaseca P, Sir-Petermann T, et al. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. J Hepatol. 2007;47:412\u20137.","journal-title":"J Hepatol"},{"key":"331_CR8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.cgh.2006.10.010","volume":"5","author":"M Gambarin-Gelwan","year":"2007","unstructured":"Gambarin-Gelwan M, Kinkhabwala SV, Schiano TD, Bodian C, Yeh HC, Futterweit W. Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clin Gastroenterol Hepatol. 2007;5:496\u2013501.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"331_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/0974-1208.112370","volume":"6","author":"R Karoli","year":"2013","unstructured":"Karoli R, Fatima J, Chandra A, Gupta U, Islam FU, Singh G. Prevalence of hepatic steatosis in women with polycystic ovary syndrome. J Hum Reprod Sci. 2013;6:9\u201314.","journal-title":"J Hum Reprod Sci"},{"key":"331_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-physiol-021115-105331","volume":"78","author":"JT Haas","year":"2016","unstructured":"Haas JT, Francque S, Staels B. Pathophysiology and mechanisms of nonalcoholic fatty liver disease. Annu Rev Physiol. 2016;78:181\u2013205.","journal-title":"Annu Rev Physiol"},{"key":"331_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jhep.2009.04.012","volume":"51","author":"S McPherson","year":"2009","unstructured":"McPherson S, Jonsson JR, Cowin GJ, O'Rourke P, Clouston AD, Volp A, et al. Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. J Hepatol. 2009;51:389\u201397.","journal-title":"J Hepatol"},{"key":"331_CR12","first-page":"1388","volume":"64","author":"G Marchesini","year":"2016","unstructured":"Marchesini G, Day CP, Dufour JF, Canbay A, Nobili V, Ratziu V, et al. EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388\u2013402.","journal-title":"J Hepatol"},{"key":"331_CR13","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/jmri.24289","volume":"39","author":"JP Kuhn","year":"2014","unstructured":"Kuhn JP, Hernando D, Mensel B, Kruger PC, Ittermann T, Mayerle J, et al. Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis. J Magn Reson Imaging. 2014;39:1494\u2013501.","journal-title":"J Magn Reson Imaging"},{"key":"331_CR14","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1002\/oby.21182","volume":"23","author":"MF Xia","year":"2015","unstructured":"Xia MF, Bian H, Yan HM, Lin HD, Chang XX, Li XM, et al. Assessment of liver fat content using quantitative ultrasonography to evaluate risks for metabolic diseases. Obesity (Silver Spring). 2015;23:1929\u201337.","journal-title":"Obesity (Silver Spring)"},{"key":"331_CR15","doi-asserted-by":"publisher","first-page":"909","DOI":"10.2214\/AJR.07.4016","volume":"192","author":"M Webb","year":"2009","unstructured":"Webb M, Yeshua H, Zelber-Sagi S, Santo E, Brazowski E, Halpern Z, et al. Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. AJR Am J Roentgenol. 2009;192:909\u201314.","journal-title":"AJR Am J Roentgenol"},{"key":"331_CR16","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/j.metabol.2009.05.032","volume":"58","author":"M Mancini","year":"2009","unstructured":"Mancini M, Prinster A, Annuzzi G, Liuzzi R, Giacco R, Medagli C, et al. Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with H-1 magnetic resonance spectroscopy. Metabolism. 2009;58:1724\u201330.","journal-title":"Metabolism"},{"key":"331_CR17","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/oby.2011.302","volume":"20","author":"MF Xia","year":"2012","unstructured":"Xia MF, Yan HM, He WY, Li XM, Li CL, Yao XZ, et al. Standardized ultrasound hepatic\/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method. Obesity (Silver Spring). 2012;20:444\u201352.","journal-title":"Obesity (Silver Spring)"},{"key":"331_CR18","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1126\/science.287.5454.860","volume":"287","author":"S Ashkar","year":"2000","unstructured":"Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science. 2000;287:860\u20134.","journal-title":"Science"},{"key":"331_CR19","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1172\/JCI31986","volume":"117","author":"T Nomiyama","year":"2007","unstructured":"Nomiyama T, Perez-Tilve D, Ogawa D, Gizard F, Zhao Y, Heywood EB, et al. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest. 2007;117:2877\u201388.","journal-title":"J Clin Invest"},{"key":"331_CR20","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1210\/en.2010-1328","volume":"152","author":"M Zeyda","year":"2011","unstructured":"Zeyda M, Gollinger K, Todoric J, Kiefer FW, Keck M, Aszmann O, et al. Osteopontin is an activator of human adipose tissue macrophages and directly affects adipocyte function. Endocrinology. 2011;152:2219\u201327.","journal-title":"Endocrinology"},{"key":"331_CR21","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2337\/db09-0404","volume":"59","author":"FW Kiefer","year":"2010","unstructured":"Kiefer FW, Zeyda M, Gollinger K, Pfau B, Neuhofer A, Weichhart T, et al. Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance. Diabetes. 2010;59:935\u201346.","journal-title":"Diabetes"},{"key":"331_CR22","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1210\/jc.2007-0349","volume":"92","author":"J Gomez-Ambrosi","year":"2007","unstructured":"Gomez-Ambrosi J, Catalan V, Ramirez B, Rodriguez A, Colina I, Silva C, et al. Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J Clin Endocr Metab. 2007;92:3719\u201327.","journal-title":"J Clin Endocr Metab"},{"key":"331_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1530\/JOE-14-0203","volume":"224","author":"Y Kuwabara","year":"2015","unstructured":"Kuwabara Y, Katayama A, Tomiyama R, Piao H, Kurihara S, Ono S, et al. Gonadotropin regulation and role of ovarian osteopontin in the periovulatory period. J Endocrinol. 2015;224:49\u201359.","journal-title":"J Endocrinol"},{"key":"331_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035612","volume":"7","author":"S Patouraux","year":"2012","unstructured":"Patouraux S, Bonnafous S, Voican CS, Anty R, Saint-Paul MC, Rosenthal-Allieri MA, et al. The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease. PLoS One. 2012;7:e35612.","journal-title":"PLoS One"},{"key":"331_CR25","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1007\/s00125-011-2170-0","volume":"54","author":"FW Kiefer","year":"2011","unstructured":"Kiefer FW, Neschen S, Pfau B, Legerer B, Neuhofer A, Kahle M, et al. Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice. Diabetologia. 2011;54:2132\u201342.","journal-title":"Diabetologia"},{"key":"331_CR26","unstructured":"Zhou BF, Cooperative Meta-Analysis Group of the Working Group on Obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;15:83\u201396."},{"key":"331_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/01.ogx.0000197817.93201.04","volume":"61","author":"DE Lane","year":"2006","unstructured":"Lane DE. Polycystic ovary syndrome and its differential diagnosis. Obstet Gynecol Surv. 2006;61:125\u201335.","journal-title":"Obstet Gynecol Surv"},{"key":"331_CR28","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1177\/000456328302000502","volume":"20","author":"GD Carter","year":"1983","unstructured":"Carter GD, Holland SM, Alaghbandzadeh J, Rayman G, Dorringtonward P. Wise PH. Investigation of hirsutism - testosterone is not enough. Ann Clin Biochem. 1983;20:262\u20133.","journal-title":"Ann Clin Biochem"},{"key":"331_CR29","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1210\/jc.2012-1382","volume":"97","author":"H Jones","year":"2012","unstructured":"Jones H, Sprung VS, Pugh CJA, Daousi C, Irwin A, Aziz N, et al. Polycystic ovary syndrome with Hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to Nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance. J Clin Endocr Metab. 2012;97:3709\u201316.","journal-title":"J Clin Endocr Metab."},{"key":"331_CR30","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412\u20139.","journal-title":"Diabetologia"},{"key":"331_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1172\/JCI105534","volume":"46","author":"HS Seltzer","year":"1967","unstructured":"Seltzer HS, Allen EW, Herron AL Jr, Brennan MT. Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest. 1967;46:323\u201335.","journal-title":"J Clin Invest"},{"key":"331_CR32","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2337\/diab.42.11.1663","volume":"42","author":"SE Kahn","year":"1993","unstructured":"Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 1993;42:1663\u201372.","journal-title":"Diabetes"},{"key":"331_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1530\/EJE-15-1074","volume":"174","author":"A Saklamaz","year":"2016","unstructured":"Saklamaz A, Calan M, Yilmaz O, Kume T, Temur M, Yildiz N, et al. Polycystic ovary syndrome is associated with increased osteopontin levels. Eur J Endocrinol. 2016;174:415\u201323.","journal-title":"Eur J Endocrinol"},{"key":"331_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/hepr.12166","volume":"44","author":"S Nagoshi","year":"2014","unstructured":"Nagoshi S. Osteopontin: versatile modulator of liver diseases. Hepatol Res. 2014;44:22\u201330.","journal-title":"Hepatol Res"},{"key":"331_CR35","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1158\/1055-9965.EPI-09-1077","volume":"19","author":"P Sreekanthreddy","year":"2010","unstructured":"Sreekanthreddy P, Srinivasan H, Kumar DM, Nijaguna MB, Sridevi S, Vrinda M, et al. Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis. Cancer Epidemiol Biomark Prev. 2010;19:1409\u201322.","journal-title":"Cancer Epidemiol Biomark Prev"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-018-0331-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12958-018-0331-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-018-0331-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T20:41:58Z","timestamp":1553632918000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-018-0331-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["331"],"URL":"https:\/\/doi.org\/10.1186\/s12958-018-0331-4","relation":{},"ISSN":["1477-7827"],"issn-type":[{"type":"electronic","value":"1477-7827"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"assertion":[{"value":"11 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All evaluations and procedures in this study were conducted according to the Declaration of Helsinki for Medical Research involving Human Subjects. This study was approved by the ethics committee of Shanghai Renji Hospital and written consent was obtained from each subject after full explanation of the purpose and nature of all procedures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"31"}}